A Randomized, Single Blind Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan ePTFE [expanded polytetrafluoroethylene] Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access.
Phase of Trial: Phase III
Latest Information Update: 16 Nov 2011
At a glance
- Drugs Paclitaxel (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Sponsors Angiotech Pharmaceuticals
- 16 Nov 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2008 The expected completion date for this trial is now 1 Apr 2009 as reported by ClinicalTrials.gov.